|
'Nearly 12,000 patent applications,
a majority of them from multinational pharma companies,
would be opened by the government on January 1 as the
government has complied its with World Trade Organisation
(WTO) obligations by issuing an ordinance to bring about
product patents for chemicals, agrochemicals and food
sectors.
Rules for operation of product patents would be notified
soon on the basis of the ordinance. The applications
are lying in the 'mailbox' provided by the government
for submission of applications in the run-up to the
introduction of product patents.
Commerce & industry minister Kamal Nath said that
patents based on the mailbox applications would be awarded
only with prospective effect. The patent will be available
from the day of award and not the day of application.
"We have specifically provided that patent rights
for mailbox applications will only be available prospectively.
We have made these changes after wide consultation,
and we feel that these considerably improve the proposals,"
he said.
Current estimates are that it will take up to 30 months
to process these applications. The government feels
that all the applications would not be pursued and it
will take a couple for years to award patents
The new provision introduced to circumscribe rights
in respect of mailbox applications to prospective effect
will protect local manufacturers from unfair charges,
said Mr Nath.
Even if a local producer manufactures a product for
which patent is granted, the liability will be limited
to the period after the grant of the patent.
Once the mailbox is opened, the list will be published
and the all stakeholders will get an opportunity to
oppose any application. The government will consider
all aspects including opposition or objections - if
any - before taking a final decision.
The government has introduced a number of safeguards
and prices of pharmaceuticals will not shoot up, Mr
Kamal Nath said. Only 3% of the drugs produced in India
now are patented, the minister added while defending
the new patent regime.
On the other hand, he claimed better options would
be available as research & development would be
encouraged by the new regime.
|